Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Sep 1;9(3):260-264.
doi: 10.4274/jcrpe.4624. Epub 2017 Jun 30.

An ABCC8 Nonsense Mutation Causing Neonatal Diabetes Through Altered Transcript Expression

Affiliations
Case Reports

An ABCC8 Nonsense Mutation Causing Neonatal Diabetes Through Altered Transcript Expression

Sarah E Flanagan et al. J Clin Res Pediatr Endocrinol. .

Abstract

The pancreatic ATP-sensitive K+ (K-ATP) channel is a key regulator of insulin secretion. Gain-of-function mutations in the genes encoding the Kir6.2 (KCNJ11) and SUR1 (ABCC8) subunits of the channel cause neonatal diabetes, whilst loss-of-function mutations in these genes result in congenital hyperinsulinism. We report two patients with neonatal diabetes in whom we unexpectedly identified recessively inherited loss-of-function mutations. The aim of this study was to investigate how a homozygous nonsense mutation in ABCC8 could result in neonatal diabetes. The ABCC8 p.Glu747* was identified in two unrelated Vietnamese patients. This mutation is located within the in-frame exon 17 and RNA studies confirmed (a) the absence of full length SUR1 mRNA and (b) the presence of the alternatively spliced transcript lacking exon 17. Successful transfer of both patients to sulphonylurea treatment suggests that the altered transcript expression enhances the sensitivity of the K-ATP channel to Mg-ADP/ATP. This is the first report of an ABCC8 nonsense mutation causing a gain-of-channel function and these findings extend the spectrum of K-ATP channel mutations observed in patients with neonatal diabetes.

Keywords: Neonatal diabetes; nonsense mutation splicing..

PubMed Disclaimer

Figures

Figure 1
Figure 1. Expression pattern of ABCC8 transcripts with and without exon 17 in human pancreas and islets. The graphs illustrate the levels of messenger RNA transcripts either containing exon 17 (black bars) or excluding exon 17 (grey bars) expressed relative to levels of the full length ABCC8 reference transcript in human islets (3 technical replicates from RNA pooled from 2 independent donors) and from human total pancreas (3 technical replicates from RNA pooled from 3 donors). Transcript levels were determined by isoform-specific qRTPCR, calculated relative to the endogenous control beta 2 microglobulin (B2M) and normalised to the amount of full length transcript present in each sample. Error bars represent the range of quantification for each sample
Figure 2
Figure 2. The reference genomic DNA sequence is provided. A dashed line denotes an exon-exon boundary. (A) Sequence analysis identified homozygosity for the SUR1Δ17 in patient 1 with the homozygous p.Glu747* ABCC8 variant in exon 17. (B) Sequence analysis of cDNA from the unaffected father who is heterozygous for the p.Glu747* variant identified a transcript which lacked exon 17 and two transcripts which contained exon 17. An alternate splice recognition site at the 3’ intron 16/exon 17 boundary results in two transcripts containing either 36 or 39 basepairs (+/- CAG boxed) (GenBank L78208 and L78224)

Similar articles

Cited by

References

    1. Flanagan SE, Clauin S, Bellanne-Chantelot C, Lonlay P, de, Harries LW, Gloyn AL, Ellard S. Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Human mutation. 2009;30:170–180. - PubMed
    1. Taschenberger G, Mougey A, Shen S, Lester LB, LaFranchi S, Shyng SL. Identification of a familial hyperinsulinism-causing mutation in the sulfonylurea receptor 1 that prevents normal trafficking and function of KATP channels. J Biol Chem. 2002;277:17139–17146. - PubMed
    1. Huopio H, Shyng SL, Otonkoski T, Nichols CG. K(ATP) channels and insulin secretion disorders. Am J Physiol Endocrinol Metab. 2002;283:207–216. - PubMed
    1. Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest. 2005;115:2047–2058. - PMC - PubMed
    1. Gribble FM, Tucker SJ, Ashcroft FM. The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide. EMBO J. 1997;16:1145–1152. - PMC - PubMed

Publication types

LinkOut - more resources